FDA Drug Application (202802) for LISDEXAMFETAMINE DIMESYLATE by ACTAVIS ELIZABETH

Back to FDA Applications sponsored by ACTAVIS ELIZABETH

Application Number202802
Product Number001
FormCAPSULE;ORAL
Dosage20MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameLISDEXAMFETAMINE DIMESYLATE
Active IngredientLISDEXAMFETAMINE DIMESYLATE

Active IngredientCount
List of drugs with Active Ingredient LISDEXAMFETAMINE DIMESYLATE2


Back to FDA Applications sponsored by ACTAVIS ELIZABETH